Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Medexus Pharmaceuticals Inc (PDDPF)

Medexus Pharmaceuticals Inc (PDDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Medexus Pharmaceuticals Reports Operating and Financial Results for the Three- and Six-Month Periods Ending September 30, 2020 Globe NewsWire - Mon Nov 16, 2020

Management to host conference call at 8:00 AM Eastern Time on Tuesday, November 17th, 2020

PDDPF : 3.2200 (unch)
MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3000 (-1.52%)
Medexus Reaches 50% Enrollment in IXINITY® Phase 4 Clinical Trial Targeting Label Expansion for Pediatric Hemophilia B Patients Globe NewsWire - Mon Nov 16, 2020

TORONTO, CHICAGO and MONTREAL, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus” ) ( TSXV: MDP , OTCQ X : MEDXF ) today announced...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (-1.52%)
Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2021 Conference Call Globe NewsWire - Mon Nov 9, 2020

Conference call to be held at 8:00 AM Eastern Time on Tuesday, November 17th, 2020

PDDPF : 3.2200 (unch)
MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3000 (-1.52%)
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders Globe NewsWire - Fri Oct 30, 2020

TORONTO and CHICAGO and MONTREAL, Oct. 30, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSXV: MDP) (OTCQX: MEDXF)   (Frankfurt: P731) announced today...

PDDPF : 3.2200 (unch)
MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3000 (-1.52%)
Medexus Appoints Michael Pine as Senior Vice President of Business Development and Strategy Globe NewsWire - Fri Sep 25, 2020

MONTREAL, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQ X : MEDXF ) , today announced the appointment of Michael Pine as...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (-1.52%)
Medexus Engages Adelaide Capital for Investor Relations Services and Reports Annual Meeting Results Globe NewsWire - Fri Sep 18, 2020

TORONTO and CHICAGO and MONTREAL, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF)   is pleased to announce that it...

PDDPF : 3.2200 (unch)
MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3000 (-1.52%)
Medexus Reports Health Canada Approval of Gleolan® (5-ALA) for Use in Guided Surgical Resection of High-Grade Gliomas Globe NewsWire - Thu Sep 10, 2020

TORONTO and CHICAGO and MONTREAL, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: MEDXF) today announces that on September...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (-1.52%)
Medexus Announces Move to a Virtual Meeting for 2020 AGM and Equity Incentive Grants Globe NewsWire - Mon Aug 24, 2020

TORONTO and CHICAGO and MONTREAL, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: PDDPF) today announced that due to public health...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (-1.52%)
Medexus Reports Triamcinolone Hexacetonide Injectable Suspension Approved for Inclusion on Quebec’s RAMQ List of Medications (Basic Plan and Institutions) Globe NewsWire - Mon Aug 24, 2020

MONTREAL, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: MEDXF) is pleased to announce that Triamcinolone Hexacetonide Injectable...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (-1.52%)
Medexus Announces New U.S. Ticker “MEDXF” on the OTCQX Globe NewsWire - Fri Aug 21, 2020

Medexus will continue to trade on the TSX Venture under ticker “MDP”

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (-1.52%)

Barchart Exclusives

2 Small-Cap Stocks With 40% to 60% Upside Barchart - 1 hour ago
Wall Street believes these two growth stocks will soar, driven by the demand for their products. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot